Pfizer (Mexico) Performance
| PFE Stock | MXN 475.00 6.97 1.49% |
Pfizer has a performance score of 4 on a scale of 0 to 100. The company holds a Beta of 0.38, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Pfizer's returns are expected to increase less than the market. However, during the bear market, the loss of holding Pfizer is expected to be smaller as well. Pfizer Inc right now holds a risk of 1.46%. Please check Pfizer Inc standard deviation, treynor ratio, downside variance, as well as the relationship between the total risk alpha and value at risk , to decide if Pfizer Inc will be following its historical price patterns.
Risk-Adjusted Performance
Soft
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Pfizer Inc are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
Pfizer |
Pfizer Relative Risk vs. Return Landscape
If you would invest 45,485 in Pfizer Inc on November 30, 2025 and sell it today you would earn a total of 2,015 from holding Pfizer Inc or generate 4.43% return on investment over 90 days. Pfizer Inc is generating 0.0815% of daily returns assuming 1.4594% volatility of returns over the 90 days investment horizon. Simply put, 13% of all stocks have less volatile historical return distribution than Pfizer, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Pfizer Target Price Odds to finish over Current Price
The tendency of Pfizer Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 475.00 | 90 days | 475.00 | nearly 4.07 |
Based on a normal probability distribution, the odds of Pfizer to move above the current price in 90 days from now is nearly 4.07 (This Pfizer Inc probability density function shows the probability of Pfizer Stock to fall within a particular range of prices over 90 days) .
Pfizer Price Density |
| Price |
Predictive Modules for Pfizer
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Pfizer Inc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Pfizer Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Pfizer is not an exception. The market had few large corrections towards the Pfizer's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Pfizer Inc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Pfizer within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.01 | |
β | Beta against Dow Jones | 0.38 | |
σ | Overall volatility | 11.33 | |
Ir | Information ratio | -0.03 |
Pfizer Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Pfizer for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Pfizer Inc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| About 70.0% of the company shares are owned by institutional investors |
Pfizer Fundamentals Growth
Pfizer Stock prices reflect investors' perceptions of the future prospects and financial health of Pfizer, and Pfizer fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Pfizer Stock performance.
| Return On Equity | 0.37 | |||
| Return On Asset | 0.13 | |||
| Profit Margin | 0.31 % | |||
| Operating Margin | 0.39 % | |||
| Current Valuation | 5.97 T | |||
| Shares Outstanding | 5.61 B | |||
| Price To Earning | 27.15 X | |||
| Price To Book | 3.26 X | |||
| Price To Sales | 59.69 X | |||
| Revenue | 100.33 B | |||
| EBITDA | 39.58 B | |||
| Cash And Equivalents | 33.31 B | |||
| Cash Per Share | 5.93 X | |||
| Total Debt | 34.76 B | |||
| Debt To Equity | 0.46 % | |||
| Book Value Per Share | 16.51 X | |||
| Cash Flow From Operations | 32.58 B | |||
| Earnings Per Share | 102.78 X | |||
| Total Asset | 181.48 B | |||
About Pfizer Performance
Evaluating Pfizer's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Pfizer has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Pfizer has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. PFIZER INC operates under Drug ManufacturersGeneral classification in Mexico and is traded on Mexico Stock Exchange. It employs 79000 people.Things to note about Pfizer Inc performance evaluation
Checking the ongoing alerts about Pfizer for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Pfizer Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| About 70.0% of the company shares are owned by institutional investors |
- Analyzing Pfizer's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Pfizer's stock is overvalued or undervalued compared to its peers.
- Examining Pfizer's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Pfizer's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Pfizer's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Pfizer's stock. These opinions can provide insight into Pfizer's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Pfizer Stock Analysis
When running Pfizer's price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.